These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Recent results of irinotecan therapy in colorectal cancer]. Láng I; Hitre E Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572 [TBL] [Abstract][Full Text] [Related]
5. Current therapies for advanced colorectal cancer. Aggarwal S; Chu E Oncology (Williston Park); 2005 Apr; 19(5):589-95. PubMed ID: 15945340 [TBL] [Abstract][Full Text] [Related]
6. The role of new agents in the treatment of colorectal cancer. Folprecht G; Köhne CH Oncology; 2004; 66(1):1-17. PubMed ID: 15031593 [TBL] [Abstract][Full Text] [Related]
8. Chemotherapy in elderly patients with colorectal cancer. Köhne CH; Folprecht G; Goldberg RM; Mitry E; Rougier P Oncologist; 2008 Apr; 13(4):390-402. PubMed ID: 18448553 [TBL] [Abstract][Full Text] [Related]
9. Outcomes in elderly patients with advanced colorectal cancer treated with capecitabine: a population-based analysis. Ho C; Ng K; O'Reilly S; Gill S Clin Colorectal Cancer; 2005 Nov; 5(4):279-82. PubMed ID: 16356306 [TBL] [Abstract][Full Text] [Related]
11. Improved first-line chemotherapy: a better chance for surgery? Tejpar S; Van Cutsem E; Adam R Lancet Oncol; 2010 Jan; 11(1):4-5. PubMed ID: 19942480 [No Abstract] [Full Text] [Related]
12. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin. Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749 [TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy of patients with colorectal carcinoma]. Punt CJ Ned Tijdschr Geneeskd; 2005 Jun; 149(26):1441-7. PubMed ID: 16010954 [TBL] [Abstract][Full Text] [Related]
14. Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases. Reddy SK; Morse MA; Hurwitz HI; Bendell JC; Gan TJ; Hill SE; Clary BM J Am Coll Surg; 2008 Jan; 206(1):96-106. PubMed ID: 18155574 [TBL] [Abstract][Full Text] [Related]
15. Advanced colorectal cancer: current treatment and nursing management with economic considerations. Viale PH; Fung A; Zitella L Clin J Oncol Nurs; 2005 Oct; 9(5):541-52. PubMed ID: 16235581 [TBL] [Abstract][Full Text] [Related]
16. Secondary hepatic resection as a therapeutic goal in advanced colorectal cancer. Saif MW World J Gastroenterol; 2009 Aug; 15(31):3855-64. PubMed ID: 19701965 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic and biologic agents as radiosensitizers in rectal cancer. Zhu AX; Willett CG Semin Radiat Oncol; 2003 Oct; 13(4):454-68. PubMed ID: 14586834 [TBL] [Abstract][Full Text] [Related]
18. Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer. Moosmann N; Heinemann V Clin Colorectal Cancer; 2008 Mar; 7(2):110-7. PubMed ID: 18501070 [TBL] [Abstract][Full Text] [Related]
19. In vivo activity of novel capecitabine regimens alone and with bevacizumab and oxaliplatin in colorectal cancer xenograft models. Kolinsky K; Shen BQ; Zhang YE; Kohles J; Dugan U; Zioncheck TF; Heimbrook D; Packman K; Higgins B Mol Cancer Ther; 2009 Jan; 8(1):75-82. PubMed ID: 19139115 [TBL] [Abstract][Full Text] [Related]
20. [Advances in new chemotherapeutic drugs for preoperative chemoradiation of locally advanced rectal cancer]. Xiao L; Gao Y; Liu M Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jan; 17(1):93-7. PubMed ID: 24519058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]